Jing Cheng

Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial

Binghe Xu, Min Yan, Fei Ma et al. · The Lancet Oncology · 2021 · 393 citations

Medicine, Oncology, Pharmacology +16

Global analysis of gene expression in invasion by a lung cancer model.

Jeremy J.W. Chen, Konan Peck, Tse-Ming Hong et al. · PubMed · 2001 · 191 citations

Medicine, Cell Biology, Molecular Biology +17

Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients

Yu-Mei Feng, Baocun Sun, Xiaoqing Li et al. · Breast Cancer Research and Treatment · 2006 · 119 citations

Medicine, Bioinformatics, Oncology +17

Comparison of the effects of imputation methods for missing data in predictive modelling of cohort study datasets

Jiahang Li, Shuxia Guo, Rulin Ma et al. · BMC Medical Research Methodology · 2024 · 118 citations · Full text

Computing, Biostatistics, Data Science +17

Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial

Pin Zhang, Tao Sun, Qingyuan Zhang et al. · The Lancet Oncology · 2017 · 60 citations

Medicine, Oncology, Pharmacology +16